Enterococcus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on mannitol salt agar[J].生物学前沿(英文版),2012,(02):167-177.doi:10.1007/sl1515-012-1183-5.Quiloan MLG, Vu J, Carvalho J.Enterococcus ...
A child’s first contact with microbes is usually assumed to occur after the rupture of the sterile amniotic sac. However, the placenta and the first stool of infants have been found to contain a full complement of microbes [26,27] and a labeled strain ofEnterococcus faeciumhas been shown t...
The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clearly attracted global attention, with a range of existing and upcoming funding, policy, and legislative initiatives designed to revive antibacterial R&D. It is essential to assess...
Entero- coccus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on... MLG Quiloan,VU John,J Carvalho - 生物学前沿 被引量: 7发表: 2012年 Enterococcus faecalis can be distinguished from Enterococcus faecium ...
aureus and Enterococcus faecalis but is not active against G-ve bacteria due to a lack of intracellular accumulation [111]. It was shown that two molecules of 16 bound to the minor groove of dsDNA, which then interfered with tran- scription, the supercoiling action of gyrase, and the ...
pneumoniae and Enterococcus faecalis [223, 226, 231, 232]. MBN-101 (39) (bismuth ethanedithiol, BisEDT) has broad spectrum, topical antibacterial and antibiofilm activ- ity, and is being developed by Microbion Corporation (Bozeman, MT, USA) [233, 234]. MBN-101 is currently being evaluated ...
The development of new and effective antibacterial drugs to treat multi-drug resistant (MDR) bacteria, especially Gram-negative (G−ve) pathogens, is acknowledged as one of the world’s most pressing health issues; however, the discovery and developmen
It is also effective against MSSA,S. epidermidisandEnterococcus faecalis, even if, like imipenem, it has lower activity againstEnterococcus faeciumand MRSA. Panipenem proved to have a good activity against anaerobes such asBacteroides fragilisand moderate activity againstClostridium difficile[36]. ...
ArticleGoogle Scholar Jiang, Y.-W. et al. Design, synthesis and biological activity of novel demethylvancomycin dimers against vancomycin-resistantEnterococcus faecalis.
3 there has been a significant shift in government and public recognition of the potential threat posed by the loss of effective therapies to treat bacterial infections, with well-publicized reports from the World Health Organization,4,5 and national governments of countries including the UK,6–8 ...